| MDIHX | SNTCX | MDIHX / SNTCX | |
| Total Expense Ratio | 1.08 | 0.77 | 140% |
| Annual Report Gross Expense Ratio | 1.10 | 0.77 | 143% |
| Fund Existence | 21 years | 20 years | - |
| Gain YTD | 8.773 | 12.105 | 72% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 44B | 320M | 13,750% |
| Annual Yield % from dividends | 1.85 | 1.70 | 109% |
| Returns for 1 year | 15.32 | 19.76 | 78% |
| Returns for 3 years | 43.57 | 40.45 | 108% |
| Returns for 5 years | 26.32 | 26.69 | 99% |
| Returns for 10 years | 131.33 | 111.19 | 118% |
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| ENS.X | 4.955740 | 0.117297 | +2.42% |
| Ethereum Name Service cryptocurrency | |||
| SEA | 17.57 | 0.14 | +0.83% |
| US Global Sea to Sky Cargo ETF | |||
| DJIA | 22.04 | 0.08 | +0.36% |
| Global X Dow 30 Covered Call ETF | |||
| DABS | 50.45 | -0.07 | -0.15% |
| Doubleline Asset-Backed Securities ETF | |||
| PPH | 106.47 | -0.73 | -0.68% |
| VanEck Pharmaceutical ETF | |||